Biochemical Characterization of MLH3 Missense Mutations Does Not Reveal an Apparent Role of MLH3 in Lynch Syndrome

Jianghua Ou, Merete Rasmussen, Helga Westers, Sofie Dabros Andersen, Paul O. Jager, Krista A. Kooi, Renee C. Niessen, Bart J. L. Eggen, Finn Cilius Nielsen, Jan H. Kleibeuker, Rolf H. Sijmons, Lene Juel Rasmussen, Robert M. W. Hofstra

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


    So far 18 MLH3 germline mutations/variants have been identified in familial colorectal cancer cases. Sixteen of these variants are amino acid substitutions of which the pathogenic nature is still unclear. These substitutions are known as unclassified variants or UVs. To clarify a possible role for eight of these MLH3 UVs identified in suspected Lynch syndrome patients, we performed several biochemical tests. We determined the protein expression and stability, protein localization and interaction of the mutant MLH3 proteins with wildtype MLH1. All eight MLH3 UVs gave protein expression levels comparable with wildtype MLH3. Furthermore, the UV-containing proteins, in contrast to previous studies, were all localized normally in the nucleus and they interacted normally with wildtype MLH1. Our different biochemical assays yielded no evidence that the eight MLH3 UVs tested are the cause of hereditary colorectal cancer, including Lynch syndrome
    TidsskriftGenes, Chromosomes & Cancer
    Udgave nummer4
    Sider (fra-til)340-350
    StatusUdgivet - 2009

    Citer dette